Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
17.60
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Dec 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Teva Pharmaceutical Industries ADR
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
Monday Markets Unhinged
May 03, 2021
Today's stock market is somewhat unhinged because so many foreign markets are shut for a bank holiday: Britain, China, Thailand, Japan.
Via
Talk Markets
9 Health Care Stocks Showing Unusual Options Activity In Today's Session
May 03, 2021
Here's the list of some unusual options activity happening in today's session: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest...
Via
Benzinga
Teva to Present New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at American Psychiatric Association Annual Meeting
May 03, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Another Heavy News Day
April 29, 2021
For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week.
Via
Talk Markets
Teva Announces the Launch of the First Generic Version of Absorica® (isotretinoin) Capsules, for the Treatment of Severe Recalcitrant Nodular Acne in Patients 12 Years of Age and Older, in the United States
April 29, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
A Heavy News Day And Crypto
April 28, 2021
Israeli TEVA reported Q1 sales which missed forecasts at $4 bn, leading to a 2.6% drop in its price earlier today.
Via
Talk Markets
Teva Pharmaceutical Industries (TEVA) Q1 2021 Earnings Call Transcript
April 28, 2021
TEVA earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Major COVID-19 Vaccine Makers Reject Teva Pharmaceutical's Offer For Jab Manufacture Help: FT
April 28, 2021
Teva Pharmaceutical Industries Ltd’s (NYSE: TEVA) CEO said that its offers to help manufacture coronavirus vaccines were turned down by major vaccine makers,...
Via
Benzinga
Exposures
COVID-19
What's Behind Teva's Mixed Q1 Results
April 28, 2021
Increased competition for several of its top products continued to affect the drugmaker's performance in Q1.
Via
The Motley Fool
Recap: Teva Pharmaceutical Q1 Earnings
April 28, 2021
Shares of Teva Pharmaceutical Indus (NYSE:TEVA) rose 1.6% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 17.11...
Via
Benzinga
Markets Are Paralyzed Ahead Of Two-Day FOMC Meeting
April 28, 2021
Strong reports from major U.S. companies are pushing indices higher. But the market is showing low volatility as investors took a temporary pause after a proposal from Joe Biden to raise taxes on...
Via
Talk Markets
Teva Earnings Top But Drugmaker's Sales Just Miss Views
April 28, 2021
Teva earnings fell less than expected but sales came in slightly below estimates for the drug giant. Teva stock was little changed.
Via
Investor's Business Daily
Teva Reports First Quarter 2021 Financial Results
April 28, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Earnings Scheduled For April 28, 2021
April 28, 2021
Companies Reporting Before The Bell • M/I Homes (NYSE:MHO) is likely to report quarterly earnings at $1.51 per share on revenue of $758.77 million. • Melco...
Via
Benzinga
Teva to Present New Analyses of AUSTEDO® (deutetrabenazine) Tablets and Assessment of Schizophrenia Clinical Outcomes at Upcoming 2021 American Psychiatric Association Annual Meeting
April 27, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
London Cancel
April 26, 2021
Brazilian Cosan is up 0.43% despite desperate Covid-19 outbreaks along the Amazon.
Via
Talk Markets
Exposures
COVID-19
This Risk Might Shock Anyone Holding Johnson & Johnson Stock
April 24, 2021
Lawsuits delayed by the pandemic could give shareholders a nasty surprise in the months ahead.
Via
The Motley Fool
Topics
Death
Lawsuit
Exposures
Death
Financial
Legal
Teva Announces Launch of its Generic Version of Canasa® (mesalamine) Suppositories To Treat Adults with Active Ulcerative Proctitis (ulcerative rectal colitis), in the United States
April 23, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Earth Day
April 22, 2021
Once again the exchanges are unsure if they want to go up or down.
Via
Talk Markets
Gold Is Back
April 21, 2021
Wednesday was another mixed day with oil stocks and foreign telcos up from demand rising--but US telcos going their own ways, with AT&T up, and Verizon down because it lost wireless subs.
Via
Talk Markets
Robots
April 19, 2021
Teva is suffering from fear of the legal risks of its opioid misselling which is overriding good news of its newer drugs.
Via
Talk Markets
New Clinical and Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection and Reduction of Migraine Burden Presented at 2021 American Academy of Neurology Virtual Annual Meeting
April 19, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Currency Manipulation
April 16, 2021
London's FTSE 100 index today rose over 7000 for the first time in 14 months. It hit 7019.53.
Via
Talk Markets
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
April 16, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
Teva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets at Upcoming 2021 American Academy of Neurology Virtual Annual Meeting, Highlighting Teva’s Ongoing Commitment to Neurology
April 15, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Stunning Market Debut
April 14, 2021
Wednesday brought a zip into the accounts of many financial stocks thanks to a boom result from Goldman Sachs GS, which boosted its competitors' prices.
Via
Talk Markets
UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots
April 14, 2021
Researchers said that a U.K. study of using different Covid-19 vaccines in two-dose inoculations is now expanded to include vaccines made by Moderna Inc (NASDAQ: ...
Via
Benzinga
Exposures
COVID-19
Electric Cancer Cure
April 13, 2021
Most US stocks were down on fear of inflation and financial risks but then rose after lunch.
Via
Talk Markets
South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report
April 12, 2021
According to a real-world data study in Israel, the coronavirus variant discovered in South Africa may dodge the protection provided by Pfizer Inc (NYSE: PFE) /...
Via
Benzinga
Exposures
COVID-19
Heavy News Day - Cheats
April 08, 2021
US job losses were up 744,000 vs a forecast of 694,000.
Via
Talk Markets
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.